Your browser doesn't support javascript.
loading
Glucose-Lowering Medications and Cardiovascular Outcomes.
Shanmugasundaram, Madhan; Pineda, J R Exequiel; Murugapandian, Sangeetha.
Affiliation
  • Shanmugasundaram M; Sarver Heart Center, Section of Cardiology, University of Arizona College of Medicine, 1501 N Campbell Avenue, Tucson, AZ, 85724, USA. msundaram@shc.arizona.edu.
  • Pineda JRE; Sarver Heart Center, Section of Cardiology, University of Arizona College of Medicine, 1501 N Campbell Avenue, Tucson, AZ, 85724, USA.
  • Murugapandian S; Division of Nephrology, University of Arizona College of Medicine, Tucson, AZ, USA.
Curr Cardiol Rep ; 23(4): 24, 2021 03 02.
Article in En | MEDLINE | ID: mdl-33655453

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pharmaceutical Preparations / Cardiovascular Diseases / Diabetes Mellitus, Type 2 / Dipeptidyl-Peptidase IV Inhibitors / Sodium-Glucose Transporter 2 Inhibitors Type of study: Risk_factors_studies Limits: Humans Language: En Journal: Curr Cardiol Rep Journal subject: CARDIOLOGIA Year: 2021 Document type: Article Affiliation country: Estados Unidos Country of publication: Estados Unidos

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pharmaceutical Preparations / Cardiovascular Diseases / Diabetes Mellitus, Type 2 / Dipeptidyl-Peptidase IV Inhibitors / Sodium-Glucose Transporter 2 Inhibitors Type of study: Risk_factors_studies Limits: Humans Language: En Journal: Curr Cardiol Rep Journal subject: CARDIOLOGIA Year: 2021 Document type: Article Affiliation country: Estados Unidos Country of publication: Estados Unidos